Loss of MeCP2 expression results in a loss of interaction of MeCP2 with methylated CpG sites at the promoter, thereby upregulating the expression of a subset of genes in Rett syndrome in mouse models as well as in human patients [44], [45]. This evidence concerns the gene MECP2 and atypical Rett syndrome.